Le Lézard
Classified in: Health, Covid-19 virus
Subject: SVY

Sleep Foundation releases series, COVID-19 and Sleep: an Ongoing Concern


SEATTLE, April 21, 2021 /PRNewswire/ -- Sleep Foundation (sleepfoundation.org) has released an article series, COVID-19 and Sleep: an Ongoing Concern, which explores how the COVID-19 pandemic has affected the waking and sleeping hours of the global population.

Within the series, Sleep Foundation examines the effects of the COVID-19 pandemic on sleep in:

Each article has been developed with the most recent information and expert-reviewed, plus consistently updated using any new data that are shared by both government agencies as well as subject-matter experts.

Elise Chahine, Editor-in-Chief of Sleep Foundation, says, "We are still not free of the COVID-19 pandemic, which is having a major impact on sleep habits and hygiene, demonstrated by the approximately 40% of Americans who reported sleep issues since the beginning of the pandemic?enter 'coronasomnia'. With the global rollout of vaccinations?more than 7.79 billion administered worldwide?plus new data emerging from infection-rate spikes and lulls, we believe it is our responsibility to keep our readers abreast of the latest findings from researchers and government organizations."

About Sleep Foundation
Sleep Foundation (SleepFoundation.org), a OneCare Media company, has a mission to improve health and wellbeing through sleep health and information. A premier sleep destination, Sleep Foundation boasts a medical advisory board of physicians, psychologists, academic researchers, as well as a seasoned team of product and materials science experts to elevate both health information and sleep product review content for the general public.

SOURCE OneCare Media


These press releases may also interest you

at 16:05
Data I/O Corporation , the leading global provider of advanced security and data deployment solutions for microcontrollers, security ICs and memory devices, today announced financial results for the first quarter ended March 31, 2024. First Quarter...

at 16:05
SkyWest, Inc. ("SkyWest") today reported financial and operating results for Q1 2024, including net income of $60 million, or $1.45 per diluted share, compared to net loss of $22 million, or $0.45 loss per share, for Q1 2023. Commenting on the...

at 16:05
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today...

at 16:05
Gilead Sciences, Inc. announced today its first quarter 2024 results of operations. "Gilead delivered another strong quarter of revenue growth in the first quarter with 6% year-over-year growth in our base business driven by HIV, Oncology and...

at 16:05
Orchid Island Capital, Inc. ("Orchid" or the "Company"), a real estate investment trust ("REIT"), today announced results of operations for the three month period ended March 31, 2024. First Quarter 2024 Results Net income of $19.8 million, or...

at 15:34
Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ("Nextdoor" or the...



News published on and distributed by: